Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Sotera Health (SHC)

Sotera Health names Kenneth Krause to board; Mihas resigns as director

Neutral Impact 2 of 5 leadership Written later

Sotera Health appointed Kenneth D. Krause as a Class I director effective March 16, 2026, and he will serve on the Audit and Litigation Committees. Constantine S. Mihas resigned from the same board seat, effective the same day, after some stockholders lost the right to designate that many directors; the filing says the resignation was not due to a disagreement with the company.

Key points

  • Krause appointed by the Board on March 15, 2026, effective March 16, 2026
  • Mihas notified the Board on March 12, 2026 of his resignation as a Class I director, effective March 16, 2026
  • Resignation tied to a reduction in the number of directors certain stockholders may designate; no disagreement cited
  • Krause is Executive Vice President and CFO of Rollins, Inc. since September 2022 and was previously CFO of MSA Safety

The filing

CompanySotera Health (SHC)
Form8-K, current report
Filed with the SECMar 16, 2026, 7:14 AM ET
Accession number0001822479-26-000019

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:00 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 16, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.